New Screening Tool Could Improve the Survival Rate of Patients with Hepatocellular Carcinoma from 20% to 90% (IMAGE)

Elsevier

New Screening Tool Could Improve the Survival Rate of Patients with Hepatocellular Carcinoma from 20% to 90%

Caption

Investigators used serum fusion transcripts to assess the risk of hepatocellular carcinoma (HCC) and the impact of cancer treatment through machine learning.

Credit

The American Journal of Pathology

Usage Restrictions

Please include attribution.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.